Withdrawn to
give FDA additional time to respond to OMB questions on this
collection. FDA may resubmit this with responses as soon as they
are ready (no additional Federal Register notice re- quired).
Inventory as of this Action
Requested
Previously Approved
0
0
0
0
0
0
0
0
0
The collection require sponsores of
any drug, biologic or device marketing application to certify to
the absence of clinical investigators and/or disclose those
financial interest as required, when covered clinical studies are
submitted to FDA in support of product marketing.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.